Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Newell

Showing results (341-350 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|February 1, 1992
Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation schemeM A Graham, D R Newell, B J Foster, et al.
Faraday Discussions|March 29, 2012
Controlled redistribution of vibrational population by few-cycle strong-field laser pulsesWilliam A Bryan, C R Calvert, R B King, et al.
Cancer|June 1, 1972
Prognostic indicators in Hodgkin's diseaseL M Axtell, M H Myers, L H Thomas, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 1974
Lead encephalopathy in the developing rat: effect on cortical ontogenesisM R Krigman, M J Druse, T D Traylor, et al.
Journal of the National Cancer Institute|February 1, 1986
Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 1973-82M R Spitz, J G Sider, C C Johnson, et al.
Biochimie|January 1, 1995
The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapyR J Griffin, N J Curtin, D R Newell, et al.
Advances in Enzyme Regulation|January 1, 1989
Thymidylate synthase: a target for anticancer drug designK R Harrap, A L Jackman, D R Newell, et al.
Seminars in Oncology|April 1, 1991
The pharmacokinetics of oral lonidamine in breast and lung cancer patientsD R Newell, J Mansi, J Hardy, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
British Journal of Cancer|January 1, 1997
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapyB Peng, M J Tilby, M W English, et al.
Pageof 52

Showing results (341-350 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|February 1, 1992
Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation schemeM A Graham, D R Newell, B J Foster, et al.
Faraday Discussions|March 29, 2012
Controlled redistribution of vibrational population by few-cycle strong-field laser pulsesWilliam A Bryan, C R Calvert, R B King, et al.
Cancer|June 1, 1972
Prognostic indicators in Hodgkin's diseaseL M Axtell, M H Myers, L H Thomas, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 1974
Lead encephalopathy in the developing rat: effect on cortical ontogenesisM R Krigman, M J Druse, T D Traylor, et al.
Journal of the National Cancer Institute|February 1, 1986
Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 1973-82M R Spitz, J G Sider, C C Johnson, et al.
Biochimie|January 1, 1995
The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapyR J Griffin, N J Curtin, D R Newell, et al.
Advances in Enzyme Regulation|January 1, 1989
Thymidylate synthase: a target for anticancer drug designK R Harrap, A L Jackman, D R Newell, et al.
Seminars in Oncology|April 1, 1991
The pharmacokinetics of oral lonidamine in breast and lung cancer patientsD R Newell, J Mansi, J Hardy, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
British Journal of Cancer|January 1, 1997
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapyB Peng, M J Tilby, M W English, et al.
Pageof 52